Literature DB >> 1895159

A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm.

S P Bourne1, K Patel, F Walsh, C J Popham, H B Coakham, J T Kemshead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1895159     DOI： 10.1007/bf00146871

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  26 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Adult human brain expresses four different molecular forms of neural cell adhesion molecules.

Authors:  S Bhat; D H Silberberg
Journal:  Neurochem Int       Date:  1988       Impact factor: 3.921

3.  K562--a human erythroleukemic cell line.

Authors:  L C Andersson; K Nilsson; C G Gahmberg
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing.

Authors:  B A Cunningham; J J Hemperly; B A Murray; E A Prediger; R Brackenbury; G M Edelman
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

Review 6.  Cell adhesion and the molecular processes of morphogenesis.

Authors:  G M Edelman
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

7.  Misidentified cell.

Authors:  M R Stratton; B R Reeves; C S Cooper
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

8.  Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12).

Authors:  C Turc-Carel; I Philip; M P Berger; T Philip; G M Lenoir
Journal:  Cancer Genet Cytogenet       Date:  1984-05

9.  Human fetal muscle-specific antigen is restricted to regenerating myofibers in diseased adult muscle.

Authors:  O Hurko; F S Walsh
Journal:  Neurology       Date:  1983-06       Impact factor: 9.910

10.  Comparative studies between a new human rhabdomyosarcoma cell line, JR-1 and its tumour of origin.

Authors:  J Clayton; J R Pincott; J A van den Berghe; J T Kemshead
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640
View more
  10 in total

Review 1.  Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

2.  Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program.

Authors:  Andrew C Wood; John M Maris; Richard Gorlick; E Anders Kolb; Stephen T Keir; C Patrick Reynolds; Min H Kang; Jianrong Wu; Raushan T Kurmasheva; Kathleen Whiteman; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2013-06-24       Impact factor: 3.167

3.  Structural mosaicism on the submicron scale in the plasma membrane.

Authors:  R Simson; B Yang; S E Moore; P Doherty; F S Walsh; K A Jacobson
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

4.  Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?

Authors:  Robin Wachowiak; Tamina Rawnaq; Roman Metzger; Alexander Quaas; Henning Fiegel; Nils Kähler; Udo Rolle; Jakob R Izbicki; Jussuf Kaifi; Holger Till
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

5.  The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis.

Authors:  M Jensen; K Ernestus; J Kemshead; M Klehr; M S Von Bergwelt-Baildon; T Schinköthe; J L Schultze; F Berthold
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

6.  The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.

Authors:  Y Olabiran; J A Ledermann; N J Marston; G M Boxer; R Hicks; R L Souhami; S G Spiro; R A Stahel
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

7.  Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma.

Authors:  Miikka Korja; Anne Jokilammi; Toivo T Salmi; Hannu Kalimo; Tarja-Terttu Pelliniemi; Jorma Isola; Immo Rantala; Hannu Haapasalo; Jukka Finne
Journal:  BMC Cancer       Date:  2009-02-17       Impact factor: 4.430

8.  Differential effects of over-expressed neural cell adhesion molecule isoforms on myoblast fusion.

Authors:  D Peck; F S Walsh
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

9.  Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry.

Authors:  V Papanastassiou; B L Pizer; H B Coakham; J Bullimore; T Zananiri; J T Kemshead
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

10.  Altered secondary myogenesis in transgenic animals expressing the neural cell adhesion molecule under the control of a skeletal muscle alpha-actin promoter.

Authors:  S Fazeli; D J Wells; C Hobbs; F S Walsh
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.